Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Запорізький Державний Медичний Університет, Георгій Вікторович Бачурін, Віктор Іванович БачурінfiledCriticalЗапорізький Державний Медичний Університет
Priority to UAU201312436UpriorityCriticalpatent/UA89024U/en
Publication of UA89024UpublicationCriticalpatent/UA89024U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for the complex treatment of ureterolithiasis comprises the lithotripsy followed by the conventional lithokinetic therapy (spasmolytics, alpha-1-adrenoblockers) and Flavia used for 30 days after the lithotripsy. Flavia is taken at a dose of one capsule thrice a day. Furthermore, Thiotriasolin 2.5 % is injected intramuscularly in a volume of 2.0 mL twice a day for 5 days followed by oral administration of 1 tablet (200 mg) thrice a day for 3 weeks.
UAU201312436U2013-10-232013-10-23Method for complex treatment of ureterolithiasis
UA89024U
(en)
Method to treat a human patient with multiple sclerosis with laquinimod, at a daily dose of about 1.2mg; an oral unit dosage form of 1.2 mg of laquinimod and a carrier